1328 ET - Altria Chief Executive Billy Gifford said he hopes job cuts at the FDA will come with a review of the organization's processes to improve efficiency. Jim Jones, the FDA's deputy commissioner for human foods, resigned Monday, citing dozens of layoffs since Trump took office. In a conference presentation Wednesday, Gifford emphasized the need for FDA approval of e-vapor products as Altria aims to make its NJOY e-cigarette business profitable. The CEO said there is a significant demand for smoke-free alternatives, but Altria is struggling to meet it due to regulatory barriers. "In the absence of FDA authorization of flavored product choices, consumers have turned to the illicit flavored disposable market," Gifford said. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
February 19, 2025 13:28 ET (18:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。